Evidence map›Paper›PMID 39942753›Full record

ArticleMolecules (Basel, Switzerland)2025

Optimization of Gelatin and Crosslinker Concentrations in a Gelatin/Alginate-Based Bioink with Potential Applications in a Simplified Skin Model.

Aida Cavallo, Giorgia Radaelli, Tamer Al Kayal, Angelica Mero, Andrea Mezzetta, Lorenzo Guazzelli, Giorgio Soldani, Paola Losi

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aida CavalloInstitute of Clinical Physiology, National Research Council, 54100 Massa, Italy.
Giorgia RadaelliInstitute of Clinical Physiology, National Research Council, 54100 Massa, Italy.
Tamer Al KayalInstitute of Clinical Physiology, National Research Council, 54100 Massa, Italy.
Angelica MeroDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Andrea MezzettaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4540-9948
Lorenzo GuazzelliDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-4655-2946
Giorgio SoldaniInstitute of Clinical Physiology, National Research Council, 54100 Massa, Italy.
Paola LosiInstitute of Clinical Physiology, National Research Council, 54100 Massa, Italy.ORCID 0000-0002-1350-8626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional bioprinting allows for the fabrication of structures mimicking tissue architecture. This study aimed to develop a gelatin-based bioink for a bioprinted simplified skin model. The bioink printability and chemical-physical properties were evaluated by varying the concentrations of gelatin (10, 15, and 20%) in a semi-crosslinked alginate-based bioink and calcium chloride (100, 150, and 200 mM) in post-printing crosslinking. For increasing the gelatin concentration, the gelatin-based formulations have a shear thinning behavior with increasing viscosity, and the filament bending angle increases, the spreading ratio value approaches 1, and the shape fidelity and the printing resolution improve. However, the formulation containing 20% of gelatin was not homogeneous, resulting also in poor printability properties. The morphology of the pores, degradation, and swelling depend on gelatin and CaCl

Indexed as

AlginatesBioprintingCross-Linking ReagentsGelatinInkSkinCalcium ChlorideFibroblastsHumansKeratinocytesPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsAlginatesCalcium ChlorideCross-Linking ReagentsGelatin3D bioprintingcalcium chloride crosslinkergelatin-based bioinkskin model

Identifiers

PMID39942753
PMCPMC11820930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.